Tranexamic Acid Tablets Recalled for Failed Manufacturing Specifications
Amring Pharmaceuticals is recalling 48,989 bottles of Lysteda (tranexamic acid) USP 650 mg tablets due to failed manufacturing specifications for impurities and degradation. The affected lots did not meet conductivity specifications during quality testing.
- Product
- TRANEXAMIC ACID — TRANEXAMIC ACID (TRANEXAMIC ACID)
- Category
- Drug
- Distribution
- Distributed nationwide